Repare Therapeutics Ownership | Who Owns Repare Therapeutics?

Overview Forecast RevenueFinancials Chart

Repare Therapeutics Ownership Summary

Repare Therapeutics is owned by 76.28% institutional investors, 0.95% insiders, and 22.76% retail investors. Bvf inc/il is the largest institutional shareholder, holding 24.47% of RPTX shares. ARK Genomic Revolution is the top mutual fund, with 5.87% of its assets in Repare Therapeutics shares.

RPTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Repare Therapeutics	76.28%	0.95%	22.76%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bvf inc/il	10.33M	24.47%	$34.10M
Blue owl capital lp	3.37M	7.99%	$11.13M
Orbimed advisors	3.32M	7.87%	$10.96M
Versant venture management	2.65M	6.27%	$8.73M
Ark investment management	2.63M	6.23%	$8.68M
Mpm asset management	2.24M	5.31%	$7.40M
Redmile group	1.94M	4.60%	$6.41M
Bioimpact capital	1.64M	3.88%	$5.41M
Aquilo capital management	956.93K	2.27%	$3.16M
Renaissance	458.70K	1.09%	$1.51M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Versant venture management	2.65M	11.30%	$8.73M
Mpm asset management	2.24M	4.06%	$7.40M
Blue owl capital lp	3.37M	3.10%	$11.13M
Aquilo capital management	956.93K	3.04%	$3.16M
Bvf inc/il	10.33M	0.96%	$34.10M
Bioimpact capital	1.64M	0.84%	$5.41M
Redmile group	1.94M	0.39%	$6.41M
Orbimed advisors	3.32M	0.22%	$10.96M
Ark investment management	2.63M	0.08%	$8.68M
Gsa capital partners llp	299.65K	0.07%	$989.00K

Top Buyers

Holder	Shares	% Assets	Change
Aquilo capital management	956.93K	3.04%	323.66K
Acadian asset management	417.93K	0.00%	284.04K
Blue owl capital lp	3.37M	3.10%	250.00K
Gsa capital partners llp	299.65K	0.07%	173.45K
Squarepoint ops	142.97K	0.00%	115.92K

Top Sellers

Holder	Shares	% Assets	Change
Deep track capital, lp	-	-	-904.26K
Artal group	-	-	-700.00K
Ensign peak advisors	-	-	-344.33K
Highvista strategies	-	-	-165.17K
Corton capital	-	-	-75.09K

New Positions

Holder	Shares	% Assets	Change	Value
Ieq capital	38.38K	0.00%	38.38K	$126.66K
Xtx topco	33.32K	0.01%	33.32K	$109.96K
Engineers gate manager lp	14.76K	0.00%	14.76K	$48.72K
Prudential financial	13.60K	0.00%	13.60K	$44.88K

Sold Out

Holder	Change
Citigroup	-34.00
Qube research	-299.00
Ubs group	-518.00
Entrypoint capital	-1.00K
Quantbot technologies lp	-2.04K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	57	-10.94%	32,384,039	-4.15%	76	1.19%	19	-26.92%	18	-
Jun 30, 2024	64	-13.51%	33,787,658	-4.85%	80	1.13%	26	23.81%	18	-30.77%
Mar 31, 2024	74	2.78%	35,510,875	-2.75%	84	1.12%	21	-34.38%	26	18.18%
Dec 31, 2023	72	-15.29%	36,516,656	0.76%	86	1.17%	32	-	22	10.00%
Sep 30, 2023	85	6.25%	36,241,949	1.19%	86	1.19%	32	6.67%	20	-23.08%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
ARK Genomic Revolution	2.49M	5.87%	-107.78K
ARK Genomic Revolution ETF	2.49M	5.86%	11.97K
Nikko Gbl All Biological Genome Eq MF	297.64K	0.70%	-28.36K
A4Investments SICAV SIF ACCI IlanaA2EURH	75.00K	0.18%	-
Vanguard Health Care ETF	54.97K	0.13%	-128.00
Range Cancer Therapeutics ETF	50.44K	0.12%	-
Biotech Growth Ord	49.26K	0.12%	-
Vifag 2002 SICAV	35.00K	0.08%	-
Avantis US Small Cap Equity ETF	28.48K	0.07%	-
SPDR® S&P® International Small Cap ETF	20.01K	0.05%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 01, 2024	Segal Lloyd Mitchell	PRESIDENT AND CEO	Sell	$11.53K
Mar 28, 2024	Segal Lloyd Mitchell	PRESIDENT AND CEO	Sell	$12.24K
Mar 28, 2024	Forte Steve	EVP, CHIEF FINANCIAL OFFICER	Sell	$3.81K
Apr 01, 2024	Forte Steve	EVP, CHIEF FINANCIAL OFFICER	Sell	$3.64K
Mar 28, 2024	Zinda Michael	EVP, CHIEF SCIENTIFIC OFFICER	Sell	$2.09K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	4
2024 Q1	-	16
2023 Q4	9	-
2023 Q2	-	3
2023 Q1	-	-

RPTX Ownership FAQ

Who Owns Repare Therapeutics?

Repare Therapeutics shareholders are primarily institutional investors at 76.28%, followed by 0.95% insiders and 22.77% retail investors. The average institutional ownership in Repare Therapeutics's industry, Biotech Stocks , is 47.04%, which Repare Therapeutics exceeds.

Who owns the most shares of Repare Therapeutics?

Repare Therapeutics’s largest shareholders are Bvf inc/il (10.33M shares, 24.47%), Blue owl capital lp (3.37M shares, 7.99%), and Orbimed advisors (3.32M shares, 7.87%). Together, they hold 40.32% of Repare Therapeutics’s total shares outstanding.

Does Blackrock own Repare Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Repare Therapeutics.

Who is Repare Therapeutics’s biggest shareholder by percentage of total assets invested?

Versant venture management is Repare Therapeutics’s biggest shareholder by percentage of total assets invested, with 11.30% of its assets in 2.65M Repare Therapeutics shares, valued at 8.73M$.

Who is the top mutual fund holder of Repare Therapeutics shares?

ARK Genomic Revolution is the top mutual fund holder of Repare Therapeutics shares, with 5.87% of its total shares outstanding invested in 2.49M Repare Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools